HYPDHyperion DeFi

Compare with peers → Embed

Filings with the SEC since Aug 24, 2016

617 filings, 0 in the last 30 days

SEC filing index

Latest annual reportOpen ↗

Mar 30, 2026

10-K, period to Dec 31, 2025

Latest quarterly reportOpen ↗

Aug 13, 2026

10-Q, period to Jun 30, 2026

Latest current reportOpen ↗

Oct 2, 2026

8-K: Material agreement ended, Quarterly results, Regulation FD disclosure, Other events

Filed in the last 30 days

of 617 in all

Timeline

Every filing on one line

1 yr 2 yr 3 yr

Annual report (10-K)Quarterly report (10-Q)Current report (8-K)Auditor changeCEO, CFO, COO or CAO changeRestatementLate filing noticeInsider purchaseCluster buy (3+ insiders)SEC comment letterShare offering (S-3, 424B)

20252026

All 66 events

Nov 7, 2026SEC letter SEC asked 6 questions about Form S-3 letters 2025-07-31 to 2025-12-05 · Crypto assets, Liquidity and cash, Risk factors · no closing letter yet
Oct 2, 20268-K Material agreement ended, Quarterly results, Regulation FD disclosure, Other events 8-K items 1.02, 2.02, 7.01, 8.01
Aug 13, 202610-Q Quarterly report (10-Q) period ended Jun 30, 2026
Aug 12, 20268-K Quarterly results, Regulation FD disclosure 8-K items 2.02, 7.01
Jul 8, 20268-K Director or officer change 8-K item 5.02
Jul 1, 20268-K Shareholder vote results 8-K item 5.07
Jun 5, 20268-K Other events 8-K item 8.01
Jun 2, 2026Buy Jung Hyunsu (See Remarks) bought $30K open-market purchase on Jun 1, 2026
May 15, 202610-Q Quarterly report (10-Q) period ended Mar 31, 2026
May 14, 20268-K Quarterly results, Regulation FD disclosure, Other events 8-K items 2.02, 7.01, 8.01
May 6, 2026Offering Sale of 2.8M new shares 424B5 · We are offering 2,777,778 shares of our common stock, $0.0001 par value per share, in this offering.
May 6, 20268-K Other events 8-K item 8.01
Mar 30, 2026Auditor Auditor changed: Marcum LLP → CBIZ CPAs P.C. auditor named in the 10-K
Mar 30, 202610-K Annual report (10-K) period ended Dec 31, 2025
Mar 26, 20268-K Quarterly results, Bylaws or fiscal year changed, Regulation FD disclosure 8-K items 2.02, 5.03, 7.01
Jan 5, 2026Officer CEO change Chief Executive Officer Appointment
Dec 10, 20258-K Other events 8-K item 8.01
Nov 17, 2025Offering Shelf registration: shares and other securities, amount not fixed S-3 · Warrants Debt Securities Units Rights From time to time, we may offer and sell up to $1,000,000,000 of the securities described in this prospectus separately or together in any combination, in one or more classes or series, in amounts, at prices and on terms that we will determine at the time of the
Nov 17, 20258-K Material agreement signed 8-K item 1.01
Nov 14, 202510-Q Quarterly report (10-Q) period ended Sep 30, 2025
Nov 13, 20258-K Quarterly results, Regulation FD disclosure 8-K items 2.02, 7.01
Oct 31, 20258-K Material agreement signed, Director or officer change, Regulation FD disclosure, Other events 8-K items 1.01, 5.02, 7.01, 8.01
Oct 2, 20258-K Director or officer change 8-K item 5.02
Sep 29, 20258-K Director or officer change, Regulation FD disclosure 8-K items 5.02, 7.01
Sep 24, 2025Offering At-the-market program: up to $34M of common stock 424B5 · On September 24, 2025, we entered into an amendment to the Original Sales Agreement (the “Amendment” and together with the Original Sales Agreement, the “Sales Agreement”) to increase the aggregate offering price of our common stock we may offer and sell pursuant to the Sales Agreement from up to $5
Sep 24, 20258-K Material agreement signed 8-K item 1.01
Sep 8, 20258-K Listing notice, Director or officer change 8-K items 3.01, 5.02
Aug 21, 20258-K Shareholder rights changed, Shareholder vote results 8-K items 3.03, 5.07
Aug 13, 20258-K Quarterly results 8-K item 2.02
Aug 13, 202510-Q Quarterly report (10-Q) period ended Jun 30, 2025
Jul 7, 2025Offering At-the-market program: up to $50M of common stock 424B5 · We previously entered into an amended and restated sales agreement (the “Sales Agreement”) with Chardan Capital Markets, LLC (“Chardan”), dated as of December 30, 2024, relating to the offer and sale of shares of our common stock, $0.0001 par value per share (the “common stock”), having an aggregate
Jul 2, 20258-K Director or officer change, Bylaws or fiscal year changed, Regulation FD disclosure 8-K items 5.02, 5.03, 7.01
Jun 27, 2025Offering At-the-market program: up to $50M of common stock 424B5 · We previously entered into an amended and restated sales agreement (the “Sales Agreement”) with Chardan Capital Markets, LLC (“Chardan”), dated as of December 30, 2024, relating to the offer and sale of shares of our common stock, $0.0001 par value per share (the “common stock”), having an aggregate
Jun 27, 20258-K Regulation FD disclosure, Other events 8-K items 7.01, 8.01
Jun 24, 20258-K Material agreement signed, New debt or obligation, Unregistered share sale, Director or officer change, Bylaws or fiscal year changed, Regulation FD disclosure 8-K items 1.01, 2.03, 3.02, 5.02, 5.03, 7.01
Jun 5, 20258-K Material agreement signed 8-K item 1.01
Jun 2, 2025Offering At-the-market program: up to $50M of common stock 424B5 · We previously entered into an amended and restated sales agreement (the “Sales Agreement”) with Chardan Capital Markets, LLC (“Chardan”), dated as of December 30, 2024, relating to the offer and sale of shares of our common stock, $0.0001 par value per share, having an aggregate offering price of up
May 19, 20258-K Quarterly results 8-K item 2.02
May 19, 202510-Q Quarterly report (10-Q) period ended Mar 31, 2025
May 15, 2025Late filing Late filing notice: the 10-Q will be late NT 10-Q (Form 12b-25), period ended Mar 31, 2025
May 2, 2025Auditor Auditor change 8-K item 4.01
May 2, 20258-K Listing notice 8-K item 3.01
Apr 30, 202510-K Annual report (10-K) (amended) period ended Dec 31, 2024
Apr 17, 2025Offering At-the-market program: up to $50M of common stock 424B5 · We previously entered into an amended and restated sales agreement (the “Sales Agreement”) with Chardan Capital Markets, LLC (“Chardan”), dated as of December 30, 2024, relating to the offer and sale of shares of our common stock, $0.0001 par value per share, having an aggregate offering price of up
Apr 15, 202510-K Annual report (10-K) period ended Dec 31, 2024
Mar 31, 2025Late filing Late filing notice: the 10-K will be late NT 10-K (Form 12b-25), period ended Dec 31, 2024
Mar 20, 20258-K Quarterly results, Other events 8-K items 2.02, 8.01
Feb 25, 20258-K Other events 8-K item 8.01
Feb 24, 20258-K Material agreement signed, New debt or obligation 8-K items 1.01, 2.03
Jan 31, 20258-K Other events 8-K item 8.01
Jan 28, 20258-K Other events 8-K item 8.01
Jan 24, 20258-K Shareholder vote results 8-K item 5.07
Jan 16, 2025Offering Sale of 15.8M new shares 424B3 · Shares sold
Jan 16, 20258-K Material agreement signed, Unregistered share sale 8-K items 1.01, 3.02
Dec 30, 2024Offering At-the-market program: up to $50M of common stock 424B5 · In accordance with the terms of the Sales Agreement, we may offer and sell shares of our common stock having an aggregate offering price of up to $50,000,000 from time to time through or to Chardan, acting as our agent, of which $33,586,557 remains available for sale pursuant to this prospectus supp
Dec 30, 20248-K Material agreement signed, Other events 8-K items 1.01, 8.01
Dec 13, 20248-K Listing notice 8-K item 3.01
Dec 9, 2024Offering Sale of 11.0M new shares 424B5 · We are offering directly to a certain institutional investor 11,000,000 shares (the “Shares”) of our common stock, par value $0.0001 per share (the “Common Stock”); in lieu of Common Stock, pre-funded warrants to purchase up to 9,085,025 shares of our Common Stock (the “Pre-Funded Warrants”); and wa
Dec 9, 20248-K Material agreement signed, Regulation FD disclosure 8-K items 1.01, 7.01
Nov 26, 2024Offering Sale of 9.0M new shares 424B5 · We are offering directly to a certain institutional investor 9,000,000 shares (the “Shares”) of our common stock, par value $0.0001 per share (the “Common Stock”); in lieu of Common Stock, pre-funded warrants to purchase up to 3,081,785 shares of our Common Stock (the “Pre-Funded Warrants”); and war
Nov 26, 20248-K Material agreement signed, Regulation FD disclosure 8-K items 1.01, 7.01
Nov 25, 20248-K Material agreement signed, New debt or obligation, Unregistered share sale, Director or officer change 8-K items 1.01, 2.03, 3.02, 5.02
Nov 20, 20248-K Other events 8-K item 8.01
Nov 15, 20248-K Restructuring or exit costs, Other events 8-K items 2.05, 8.01
Nov 12, 20248-K Quarterly results 8-K item 2.02
Nov 12, 202410-Q Quarterly report (10-Q) period ended Sep 30, 2024

From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).

Every filing

Newest first, by kind

Each form links to sec.gov

All 617 Annual & quarterly 38 Current reports (8-K) 161 Insiders 237 Proxy & votes 25 Big owners (13D/13G) 41 Shares & debt offered 51 SEC letters 32 Other 32

Filed	Form	What it is	Period
May 5, 2026	DEFA14A	Extra proxy material		all files
May 5, 2026	DEF 14A	Proxy statement	Jun 30, 2026	all files
Apr 17, 2026	PRE 14A		Jun 30, 2026	all files
Jul 24, 2025	DEF 14A	Proxy statement	Aug 18, 2025	all files
Jul 11, 2025	PRE 14A		Jul 10, 2025	all files
Jan 15, 2025	DEFA14A	Extra proxy material		all files
Dec 23, 2024	DEF 14A	Proxy statement	Jan 21, 2025	all files
Dec 13, 2024	PRE 14A		Dec 12, 2024	all files
May 3, 2024	DEF 14A	Proxy statement	Jun 12, 2024	all files
Apr 23, 2024	PRE 14A		Jun 12, 2024	all files
May 11, 2023	DEFA14A	Extra proxy material		all files
May 11, 2023	DEF 14A	Proxy statement	Jun 27, 2023	all files
May 2, 2022	DEFA14A	Extra proxy material		all files
May 2, 2022	DEF 14A	Proxy statement	Jun 16, 2022	all files
Apr 30, 2021	DEFA14A	Extra proxy material		all files
Apr 30, 2021	DEF 14A	Proxy statement	Jun 16, 2021	all files
Jun 11, 2020	DEFA14A	Extra proxy material		all files
Jun 5, 2020	DEFA14A	Extra proxy material		all files
Apr 29, 2020	DEFA14A	Extra proxy material		all files
Apr 29, 2020	DEF 14A	Proxy statement	Jun 11, 2020	all files
Apr 30, 2019	DEFA14A	Extra proxy material		all files
Apr 30, 2019	DEF 14A	Proxy statement	Jun 11, 2019	all files
Apr 30, 2018	DEFA14A	Extra proxy material		all files
Apr 30, 2018	DEF 14A	Proxy statement	Jun 11, 2018	all files
Apr 10, 2018	PRE 14A		Jun 11, 2018	all files

Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.

Next Earnings releases →